Originally published In Press as doi:10.1074/jbc.M201656200 on August 6, 2002
J. Biol. Chem., Vol. 277, Issue 40, 36978-36986, October 4, 2002
Cloning, Expression, and Functional Characterization of a
Ca2+-dependent Endoplasmic Reticulum Nucleoside
Diphosphatase*
Bernd U.
Failer,
Norbert
Braun, and
Herbert
Zimmermann
From the Arbeitskreis Neurochemie, Biozentrum der J. W. Goethe-Universitaet, Marie-Curie-Strasse 9, D-60439 Frankfurt am
Main, Germany
Received for publication, February 19, 2002, and in revised form, July 9, 2002
 |
ABSTRACT |
We have isolated and characterized the cDNA
encoding a Ca2+-dependent nucleoside
diphosphatase (EC 3.6.1.6) related to two secreted ATP- and
ADP-hydrolyzing apyrases of the bloodsucking insects, Cimex
lectularius and Phlebotomus papatasi. The rat
brain-derived cDNA has an open reading frame of 1209 bp encoding a
protein of 403 amino acids and a calculated molecular mass of 45.7 kDa. The mRNA was expressed in all tissues investigated,
revealing two major transcripts with varying preponderance. The
immunohistochemical analysis of the Myc-His-tagged enzyme expressed in
Chinese hamster ovary cells revealed its association with the
endoplasmic reticulum and also with pre-Golgi intermediates.
Ca2+-dependent nucleoside diphosphatase is a
membrane protein with its catalytic site facing the organelle lumen.
It hydrolyzes nucleoside 5'-diphosphates in the order UDP
>GDP = IDP >>>CDP but not ADP. Nucleoside 5'-triphosphates
were hydrolyzed to a minor extent, and no hydrolysis of nucleoside
5'-monophosphates was observed. The enzyme was strongly activated by
Ca2+, insensitive to Mg2+, and had a
Km for UDP of 216 µM.
Ca2+-dependent nucleoside diphosphatase
may support glycosylation reactions related to quality control in the
endoplasmic reticulum.
 |
INTRODUCTION |
Recently, novel enzyme families have been characterized with the
ability to hydrolyze nucleoside triphosphates and/or nucleoside diphosphates. These enzymes have in common a biosynthetic pathway involving the endoplasmic reticulum but differ regarding their cellular
location. Their catalytic sites are directed either to the lumen
of the endomembrane system or the cell surface, or they are released
from cells. This implies that they can either be involved in
intraorganellar metabolic reactions or serve extracellular nucleotide metabolism.
The seven members of the ecto-nucleoside triphosphate
diphosphohydrolase
(E-NTPDase)1 family hydrolyze
nucleoside triphosphates and diphosphates, albeit with varying
preference (review and nomenclature in Refs. 1 and 2). All of them have
a wide tissue distribution. NTPDase1 to NTPDase3 (CD39, CD39L1, CD39L3)
are typical ecto-enzymes and are thought to play a major role in
controlling intercellular signaling mediated by nucleoside tri- and
diphosphates, including platelet aggregation (3) and synaptic
transmission (4). The other four members of this enzyme family have a
predominant intracellular localization. The two closely related
variants of NTPDase4 (UDPase/hLALPv and hLALP70) are enriched in the
Golgi apparatus (UDPase) (5) and in lysosomal/autophagic vacuoles (hLALP70) (6, 7), respectively. Both enzymes hydrolyze a variety of
nucleoside tri- and diphosphates but ATP only to a minor extent. The
murine orthologue of NTPDase5 was allocated to the ER (ER-UDPase, 8).
However, expression of human NTPDase5 (CD39L4) in COS-7 cells resulted
in a secreted and soluble form of the enzyme (9), suggesting that it
predominates in the ER and can in addition be released into the
extracellular space. NTPDase6 (CD39L2) has been allocated to the Golgi
apparatus. This nucleotidase is also associated with the cell surface
and becomes secreted from transfected cells (10-13). Both enzymes
preferentially hydrolyze a variety of nucleoside diphosphates. In
addition, NTPDase7 (LALP1) reveals an intracellular (vesicular)
distribution and hydrolyzes a variety of nucleoside tri- and
diphosphates (14). At present little is known concerning the functional
role of the organelle-associated nucleotidases. Based on work with two
related and Golgi-located yeast enzymes, GDPase and Ynd1/Apy1p
(15-18), it has been suggested that the ER- and Golgi-located
mammalian species are involved in protein glycosylation reactions (5, 8, 10).
An additional family of ATP- and ADP-hydrolyzing enzymes (apyrases, EC
3.6.1.5) has been identified in bloodsucking arthropods. The bed bug,
Cimex lectularius (19), and the sand fly, Phlebotomus papatasi (20), secrete a Ca2+-dependent
apyrase from their salivary glands that facilitates hematophagy by
reducing the ADP-induced aggregation of host platelets. Heterologous
transfection of the C. lectularius apyrase in COS-7 cells
resulted in the secretion of a Ca2+-dependent
apyrase (19). Sequences related to the insect salivary apyrases can be
found in mammalian species (19, 20). It therefore appeared possible
that these encode secreted apyrases.
We have cloned and sequenced the rat homologue of the soluble
Cimex apyrase and studied its cellular distribution and
catalytic properties. Our results demonstrate that both the cellular
localization and the catalytic properties of the mammalian enzyme
differ from its insect relatives. It represents a membrane-bound
Ca2+-dependent nucleoside diphosphatase
(Ca2+-NDPase) that is targeted to the ER following
heterologous expression.
 |
EXPERIMENTAL PROCEDURES |
Material--
SuperScriptIITM human brain pCMV-SPORT 1 cDNA
library, SuperScriptIITM rat brain pCMV-SPORT 2 cDNA library,
TrizolTM reagent, reverse transcriptase
SuperScriptTMII, cell culture media Ham's F-12 and
Dulbecco's modified Eagle's medium, fetal calf serum, horse serum,
penicillin, and streptomycin were from Invitrogen. Cloning
vector pcDNA3.1(
)/Myc-His B and oligo(dT) cellulose were
purchased from Invitrogen. Hybond N membrane, [
-32P]dCTP, and the enhanced chemiluminescence system
were from Amersham Biosciences. Anti-digoxigenin alkaline
phosphatase-conjugated antibody and a chemiluminescent substrate,
(disodium
3-(4-methoxyspiro-{1,2-dioxoethane-2',3-(5'-chloro)tricyclo[3.3.1.13',7]decan}-4-yl)phenyl
phosphate), were obtained from Roche Molecular Biochemicals. Sawady
Pwo DNA polymerase was from Peqlab, Biotechnologie GmbH
(Erlangen, Germany). Taq DNA polymerase and restriction
endonucleases were purchased from MBI Fermentas (St. Leon-Rot,
Germany). Nucleoside triphosphate, diphosphate, and monophosphate
sodium salts, poly(D-lysine), phenylmethanesulfonyl fluoride, and
proteinase K were obtained from Sigma. Triton X-100 and Triton X-114
were from Serva (Heidelberg, Germany).
AlexaFluor-488TM-conjugated lectin WGA was from Molecular
Probes (Leiden, Netherlands). Rabbit anti-calnexin carboxyl terminus
polyclonal antibody was purchased from StressGen (Victoria, B.C.,
Canada), and the mouse monoclonal antibody against the Myc epitope was
derived from clone 9E10. The polyclonal CY3-labeled anti-rabbit IgG,
fluorescein isothiocyanate, CY3-labeled anti-mouse IgG antibodies, and
horseradish peroxidase-conjugated anti-rabbit secondary antibodies were
obtained from Dianova (Hamburg, Germany). The Nucleobond X-500 plasmid purification kit was purchased from Macherey and Nagel (Düren, Germany). Nitrocellulose membranes were from Schleicher & Schüll (Dassel, Germany). The protease inhibitors chymostatin, pepstatin, benzamidine, antipain, and leupeptin were obtained from Calbiochem.
cDNA Library Screening--
Electrocompetent
Escherichia coli XL10 gold were transformed with a human
brain pCMV-SPORT 1 cDNA library. Approximately 0.5 × 106 colonies were plated on Luria-Bertani/ampicillin agar
plates. A 300-bp PCR fragment (forward primer,
5'-TACCAGATCGAAGGCAGCAA-3', and reverse primer,
5'-GCAGGCAGACTCATGGATGA-3'; template human brain pCMV-SPORT 1 cDNA
library) was labeled with [
-32P]dCTP by PCR.
Transformants were screened by colony hybridization with the
radiolabeled probe. Positive signal areas were amplified and rescreened
for single positive colonies.
Amplification of cDNA and DNA Methods--
The complete
coding sequence of the rat Ca2+-NDPase was obtained by PCR
using the forward primer, 5'-CCATACAGGTCCTGTCCAGAGTGC-3', the reverse
primer, 5'-GGTTTTTATGAGTCCTGGTGTAACACAGC-3', and a rat brain pCMV-SPORT
2 cDNA library as a template. The resulting 1.3-kb fragment was
digested with XbaI and cloned into the SmaI and
XbaI restriction sites of the pCMV SPORT 1 vector. An
expression vector containing a carboxyl-terminal Myc-tagged sequence
was generated by digestion of pCMV SPORT 1/Ca2+-NDPase with
EcoRI, followed by ligation with pcDNA3.1(
)/Myc-His B. 5'-Truncated myc-tagged and non-tagged plasmids were
obtained by amplification of a 1.2-kb fragment using the forward
primer, 5'-TGAATTCCAGTGCTGGCATCCATGACC-3', the reverse primer,
5'-TAATACGACTCACTATAGGG-3', and pCMV SPORT 1/Ca2+-NDPase as
a template. The PCR fragment was digested with EcoRI and
ligated with EcoRI cut pCMV SPORT 1/Ca2+-NDPase
and pcDNA3.1(
)/Myc-His B.
cDNA Sequencing and Computational Sequence Analysis--
DNA
sequencing was performed by Scientific Research and Development GmbH
(Oberursel, Germany). The Omiga 2.0 sequence analysis program (Oxford
Molecular Ltd., Oxford, UK) was used for assembling sequencing
fragments, translating DNA into amino acid sequences, generating
hydrophobicity plots (21), and amino acid sequence alignment (CLUSTAL W
algorithm), including establishing the dendrogram. For prediction of
transmembrane domains, the software TMpred
(www.ch.embnet.org/software/TMPRED form.html) was employed. For
signal peptide and sorting analysis, SignalP 2.0 (www.cbs.dtu.dk/services/SignalP-2.0/) and PSORT II
(psort.nibb.ac.jp/form2.html) were used. The DNA and deduced amino acid
sequences were analyzed for similarity to known sequences with the NCBI
Blast Network service (www.ncbi.nlm.nih.gov/BLAST/). Protein
motif search was performed using the PROSITE data base
(pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=npsa_prosite.html).
Expression of Recombinant Proteins--
Chinese hamster ovary
(CHO) cells were cultured as previously described (22). Cells were
transfected by electroporation with one of the above
described plasmids in electroporation buffer (137 mM NaCl,
5 mM KCl, 0.7 mM
Na2HPO4, 6 mM dextrose, 20 mM Hepes at pH 7) using a BTX Electrocell manipulator 600. In control experiments cells were transfected with empty vector alone.
Preparation of Membrane Fractions--
24 h after
electroporation the culture medium of CHO cells was exchanged to remove
dead cells and debris. After an additional 10 h, sodium butyrate
was added at a final concentration of 6 mM. The conditioned
culture medium was removed 48 h after electroporation, and cells
were washed twice with phosphate-buffered saline, trypsinized, washed
twice in isotonic buffer A (140 mM NaCl, 5 mM
KCl, 5 mM CaCl2, 2 mM
MgCl2, 10 mM glucose, 10 mM Hepes,
pH 7.4), and finally centrifuged at 300 × gav. Following resuspension with buffer A, cells
were supplemented with protease inhibitors (2 µg/ml chymostatin, 1 µg/ml pepstatin, 1 mM benzamidine, 2 µg/ml antipain,
and 2 µg/ml leupeptin), homogenized, and centrifuged for 10 min at
300 × gav at 4 °C. The resulting
supernatant was centrifuged at 100,000 × gav for 45 min at 4 °C, and pellets were
resuspended in 50% glycerol and stored at
20 °C.
Measurement of Nucleotidase Activities--
Substrate
specificity was determined by incubating membrane fractions in
phosphate-free solution containing 0.02% Triton X-100, 50 mM Hepes (pH 7.0), 1 mM CaCl2, and
0.5 mM substrate. Samples were heat-inactivated for 4 min
at 95 °C prior to determination of inorganic phosphate (23). The
optimal pH range was determined using a combined buffer (50 mM Hepes and 50 mM glycine) ranging from pH 6.0 to 10.5, containing 1 mM CaCl2 and 0.5 mM UDP. Metal ion dependence was measured in 50 mM Hepes (pH 7.0), containing 0.5 mM UDP and
either CaCl2 or MgCl2 (up to 4 mM).
The Km value for UDP was determined in 50 mM Hepes (pH 7.0) and a substrate/Ca2+ ratio of
1:2. Catalytic activity of membrane fractions derived from cells
transfected with the empty plasmid was subtracted from that obtained
with cDNA-transfected cells.
Triton X-114 Partitioning--
Membrane fractions corresponding
to 0.4 × 106 cells transfected with full-length or
truncated cDNA or with the empty plasmid were diluted in 300 µl
of double distilled water, adjusted to 1% Triton X-114, and incubated
on ice for 10 min. Aliquots (50 µl) were removed as controls. The
remaining solution was incubated at 30 °C for 10 min. After
centrifugation (12,000 × gav, 25 °C, 5 min) the aqueous phase (detergent-depleted) was removed, and the
hydrophobic phase (detergent-enriched) was resuspended in ice-cold
buffer (50 mM Hepes, pH 7.0). Total, aqueous, and
hydrophobic phases were analyzed for UDPase activity (50 mM
Hepes, pH 7.0, 0.5 mM UDP, 1 mM
CaCl2, 0.1% Triton X-100).
Proteinase K Digestion--
Membrane fractions corresponding to
7,750 cells transfected with full-length cDNA or with the empty
plasmid were incubated for 30 min at 37 °C in 0.5 mM
CaCl2, 25 mM Hepes (pH 7.4) containing either
proteinase K (2.5 µg) or Triton X-100 (0.02%), proteinase K (2.5 µg) plus Triton X-100 (0.02%), or vehicle. Proteinase K activity was
stopped with phenylmethylsulfonyl fluoride at a final concentration of
1 mM. Enzyme activity was measured in 25 mM
Hepes (pH 7.4) containing 0.5 mM UDP, 1 mM
CaCl2 in the presence or absence of 0.02% Triton X-100. No
Triton X-100 was added during the enzyme assay when the effect of
proteinase K alone on nucleotidase activity was to be determined.
Inorganic phosphate was determined as described above.
Immunoblotting--
For Western blot analysis, aliquots of
membrane fraction were treated with dithiothreitol and electrophoresed
on 15% SDS-polyacrylamide gels. After electrophoresis, proteins were
transferred onto nitrocellulose membranes. Immunodetection was
performed with the anti-Myc antibody and horseradish
peroxidase-conjugated anti-rabbit secondary antibody using the
enhanced chemiluminescence method according to the manufacturer's instructions.
Immunofluorescence Staining--
24 h after transfection, CHO
cells (4 × 104) were seeded on poly(D-lysine)-coated
(10 µg/ml) glasscover slips (10 mm diameter) and cultured for an
additional 24 h. Sodium butyrate (6 mM) was added
14 h before analyzing cells. Immunofluorescence was performed either with cells fixed in methanol to analyze the intracellular distribution of antigens or with viable cells to analyze a potential surface location of the antigen (24). A monoclonal anti-Myc antibody (5 µg/ml), a rabbit anti-calnexin polyclonal antibody (diluted 1:200),
or AlexaFluor-488TM-conjugated wheat germ agglutinin (WGA)
(diluted 1:700) was applied. After application of the secondary
antibody (anti-rabbit-CY3, anti-mouse-CY3, anti-mouse-fluorescein
isothiocyanate), cells were mounted and investigated with an
epifluorescence microscope equipped with a MCID 4 imaging analysis
system (Imaging Research, St. Catharines, Ontario, Canada) or a
confocal laser scanning microscope (Leica, Bensheim, Germany).
Northern Blot Analysis--
Wistar rats (200-250 g) were
obtained from Charles River Wiga (Sulzfeld, Germany). Total RNA from
rat intestine, spleen, thymus, lung, skeletal muscle, heart, kidney,
liver, and brain were isolated with TrizolTM reagent.
Northern blot analysis with polyadenylated RNA was performed as
previously described (22). The Acc65I-digested clone, pCMV Sport 1/Ca2+-NDPase, was used as a template for the cRNA
probe. The SP6/T7 polymerase and transcription kit from Roche was used
to synthesize digoxigenin-labeled single-stranded antisense cRNA probes
in accordance with the supplier's instructions.
 |
RESULTS |
Screening of a Human Brain cDNA Library--
The C. lectularius apyrase (accession number AAD09177) was used as query
for similarity searches in expressed sequence tag (EST) databases. A
0.9-kb consensus sequence was generated from human ESTs
(GenBankTM accession numbers AA337541, BE410063, BE301945,
AW409804, and AW402618) and used for primer design. A 300-bp PCR
fragment was amplified using forward primer,
5'-TACCAGATCGAAGGCAGCAA-3', reverse primer, 5'-GCAGGCAGACTCATGGATGA-3',
and the human brain pCMV-SPORT 1 cDNA library as a template. The
fragment was radiolabeled and used for library screening. The
resulting clone contained a 786-bp coding sequence and a large
3'-untranslated region. The DNA sequence
was used for similarity search in human genome databases, leading to
sequence completion and chromosomal localization. The gene was located
twice as a triple exon variant on chromosome 17 (17q25, accession
number NT010664) and on chromosome 3 (accession number AC079359).
Amplification and Characterization of the Rat cDNA
Clone--
The putative human amino acid sequence was used for
similarity search in a mouse EST data base. The EST sequences
(GenBankTM accession numbers BF582504, AI645519, and the
later released mouse mRNA sequence AK006565, which contains an
additional 111 bp in the coding sequence) were used for primer design
(forward primer, 5'-CCATACAGGTCCTGTCCAGAGTGC-3', and reverse primer,
5'-GGTTTTTATGAGTCCTGGTGTAACACAGC-3'). A 1.3-kb PCR
fragment amplified from the rat brain
pCMV SPORT 2 cDNA library revealed an open reading frame of 1209 bp, encoding 403 amino acid residues. The deduced amino acid sequence
(Fig. 1A) contains one
putative N-glycosylation site (Asn90) and one
cysteine residue (Cys289). In addition, consensus sites for
two cAMP- and cGMP-dependent protein kinase phosphorylation
sites, six protein kinase C phosphorylation sites, six casein kinase II
phosphorylation sites, and two N-myristoylation sites could
be identified. We identified an amino-terminal
RXRXR motif between amino acid position 38 and 42 that may function as a ER retention/retrieval motif (25). The
calculated molecular mass of the encoded protein is 45.7 kDa with
an isoelectric point of 6.2. The hydrophobicity analysis predicts two
hydrophobic stretches in the polypeptide chain (Fig. 1B),
between residues 15 and 35 (weak) and between 45 and 63 (strong),
respectively. The prediction of transmembrane domains (TM) generates
two alternative models. The strongly preferred model is amino terminus
outside, first TM orientation outside to inside, second TM orientation
inside to outside, and carboxyl terminus outside (Fig. 1C).
The second model predicts only one transmembrane domain at the strongly
hydrophobic domain (45-63) with the amino terminus inside, the TM
orientation inside to outside, and carboxyl terminus outside (Fig.
1D). There are three putative start codons in-frame before
the second TM. The second start codon is part of the first TM
(Met15), whereas the third is situated 10 residues upstream
the second TM. Signal peptide analysis predicted a signal anchor
(probability 0.990) for a sequence starting with the first ATG and a
signal peptide (probability 0.656) for a sequence beginning with the third start codon in-frame. A maximum cleavage site probability of
0.495 was predicted at residue 40 of the sequence beginning with the
third start codon. For this reason a second and truncated clone was
produced by PCR amplification of a 1.2-kb fragment, beginning with the
third start codon encoding 373 amino acid residues.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 1.
DNA sequence, predicted protein sequence, and
hydrophobicity plot of rat Ca2+-NDPase. A,
the three start codons in-frame are indicated by shading.
Predicted weak and strong hydrophobic sequences are indicated by
gray and black bars, respectively. The
arrowhead depicts the position of the potential
N-glycosylation site. B, the hydrophobicity plot
was prepared by the method of Kyte and Doolittle (21) (window size: 11 residues). The two predicted transmembrane domains are labeled
peak 1, weak TM, and peak 2, strong TM. The
arrow marks the position of the third start codon utilized
in the truncated cDNA. C and D depict the
membrane topography of the full-length Ca2+-NDPase.
|
|
Relation to Other Sequences--
A mouse homologue of the cloned
rat sequence could be located on chromosome 11. An analysis of mouse
AK006565, BC020003, and the EST sequences revealed a potential splice
variant. The sequence in AK006565 contains a 37-amino acid residue
insert at position 213, as compared with the sequence in BC020003 that
is homologous to the cloned rat sequence. To investigate the possible
existence of a corresponding splice variant in the rat cDNA
library, primers were designed around the putative insert site. PCR
analysis revealed no indication of a splice variant corresponding to
the mouse AK006565 sequence (data not shown).
The deduced amino acid sequence of rat full-length
Ca2+-NDPase cDNA shares 86 and 95% amino acid identity
with the corresponding human and mouse sequences.
Ca2+-NDPase is more distantly related to the apyrases
characterized in C. lectularius and P. papatasii
(37 and 31%, respectively) and to sequences obtained from
Drosophila melanogaster and Anopheles gambiae.
Multiple sequence alignment of 10 sequences detected by similarity
searches depicts two major groups. One group is formed by the insect
sequences. Two of these have been characterized and identified as
apyrases. The second group comprises related mammalian sequences, a
sequence from the frog Silurana tropicalis and one
from the nematode Caenorhabditis elegans. No related
sequence could be detected in yeast (Saccharomyces
cerevisiae) databases.
The alignment of 10 selected sequences from vertebrate and invertebrate
sources reveals several conserved clusters of amino acid residues (Fig.
2). We identified eight motifs that are
particularly highly conserved, one of which is directly located at the
carboxyl terminus. These include amino acid positions (rat sequence)
107-116, 164-192, 199-232, 281-291, 297-305, 315-323, 345-367,
396-402. The alignment further reveals that all vertebrate sequences
contain an extended amino terminus and share the three in-frame start codons. The sequence of C. elegans begins with a methionine
corresponding to the third start codon of the mammalian sequences.
Drosophila contains the longest sequence, with three start
codons in-frame unrelated to the mammalian sequences. Although all
vertebrate sequences share the two hydrophobic stretches at the amino
terminus, the invertebrate sequences have only one predicted
hydrophobic stretch at the amino terminus. The shortest sequences are
those of the bloodsucking insects (C. lectularius and
the two sandflies, Lutzomia longipalpis and P. papatasi). No identities were observed with other nucleotide
binding or hydrolyzing enzymes.

View larger version (96K):
[in this window]
[in a new window]
|
Fig. 2.
Alignment of selected sequences.
Sequence alignment was performed using the CLUSTAL W algorithm. The
GenBankTM accession numbers of the sequences are given in
parentheses. RN, Rattus norvegicus (AJ312207); MM, Mus
musculus (BC020003); HS, Homo sapiens (NT010664); ST,
S. tropicalis (AL594966, AL645454, AL629683, AL639153, and
AL630505, EST consensus sequence); CE, C. elegans (U29378,
theoretical gene product); DM, D. melanogaster (AAF54638,
theoretical gene product); AG, A. gambiae (AJ297933,
frameshift error corrected); CL, C. lectularius (AF085499);
LL, L. longipalpis (AF131933); PP, P. papatasi
(AF261768). Eight highly conserved sequence domains are indicated by
shading. (*), single, fully conserved residues. (:), strong
group, fully conserved residues. (.), weaker group, fully conserved
residues.
|
|
Northern Blot Analysis--
To analyze the tissue distribution of
the Ca2+-NDPase, polyadenylated RNA was purified from rat
tissues and probed with a 726-bp antisense probe. Signals were obtained
for all tissues analyzed, including intestine, thymus, heart, lung,
spleen, kidney, liver, testis, skeletal muscle, and brain (Fig.
3). Two major bands, whose preponderance
considerably varied between tissues, were detected at 2.9 and 4.9 kb.
Although in several tissues the 4.9-kb form predominated, the 2.9-kb
signal was strong in lung, kidney, and brain. The 2.9-kb signal was
absent from testis. An mRNA sequence of similar size (3.3 kb) was
translated from a human cDNA library (BC017655).

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 3.
Northern blot analysis of
Ca2+-NDPase mRNA expression in various rat
tissues. Polyadenylated RNA (0.75 µg per lane) isolated from
adult rat tissues was hybridized with a 726-bp digoxigenin-labeled
riboprobe.
|
|
Expression and Biochemical Characterization--
Transfection of
CHO cells with either Myc-tagged full-length or truncated
Ca2+-NDPase cDNA revealed that both cDNAs are
expressed. Cells transfected with the empty plasmid served as a
control. Membrane fractions were subjected to Western blot analysis
(Fig. 4). After transfection with the
full-length clone, a strong immunoreactive band of 49.3 kDa and a weak
immunoreactive band of 46.8 kDa were obtained. The molecular mass of
the truncated form (46.8 kDa) was identical to that of the weak band
obtained after transfection with full-length cDNA. Because the
predicted molecular mass of the tagged recombinant full-length protein
is 49.6 kDa (untagged 45.7 KDa) and that of the tagged truncated form
46.2 kDa (untagged 42.3 KDa), it is likely that the third start codon
is used to a minor extent for protein translation. No immunoreactive
bands were obtained when the culture medium or the supernatant
fractions obtained after homogenizing transfected cells were analyzed
(data not shown). This suggests that no soluble and released form of
the protein was generated.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 4.
Western blots of full-length Myc His-tagged
Ca2+- NDPase and of the corresponding tagged 5'-truncated
protein. Membrane fractions were prepared from transfected CHO
cells, and 3.5 µg of protein was loaded per lane. In the case of the
5'-truncated protein the third start-codon in-frame was used. The
arrowhead marks a weak protein band at 46.8 kDa
corresponding to the truncated protein.
|
|
Catalytic activities were determined using membrane fractions obtained
from CHO cells transfected with the untagged full-length or truncated
cDNA or the empty plasmid (control). Transfection with either
cDNA resulted in the formation of catalytically active enzymes with
essentially identical substrate specificities and extents of product
formation (Fig. 5). Both enzymes revealed
highest activities with UDP, GDP, and IDP as substrates. Catalytic
activity was very low with CDP as a substrate and absent with ADP.
Nucleoside triphosphates were hydrolyzed to a small extent, with the
highest catalytic activity obtained with UTP and GTP. Because
commercially available nucleoside triphosphates can contain significant
amounts of nucleoside diphosphates (8, 10) it is possible that
nucleoside diphosphates contributed to the apparent nucleoside
triphosphatase activities determined. No hydrolysis was obtained with
the corresponding nucleoside monophosphates.

View larger version (10K):
[in this window]
[in a new window]
|
Fig. 5.
Substrate specificity of
Ca2+-NDPase after heterologous expression in CHO
cells. Membrane fractions were obtained from cells transfected
with the untagged full-length (black bars) or truncated
(white bars) cDNA. Substrates were applied at a
concentration of 0.5 mM in the presence of 1 mM
CaCl2. Catalytic activities were normalized to UDPase
activity. The 100% value corresponds to 73 ± 3 nmol
Pi/(106 cells × min) (± S.E.;
n = 3) for the full-length enzyme and 65 ± 38 nmol Pi/(106 cells × min) (± S.E.;
n = 3) for the 5'-truncated enzyme.
|
|
Dependence on divalent metal cations was determined using the
full-length protein and UDP, the substrate yielding the highest catalytic activity (Fig. 6). Catalytic
activity revealed a strict dependence on Ca2+. It was not
activated by Mg2+ (Fig. 6A). At a UDP
concentration of 0.5 mM, maximum activity was obtained with
1 mM Ca2+. Higher Ca2+
concentrations reduced catalytic activity. In the absence of added
divalent cations and in the presence of 1 mM EDTA,
catalytic activity amounted to 2.8% of maximal activity. Catalytic
activity was maximal between pH 6.5 and 7.5 (0.5 mM UDP, 1 mM Ca2+) (Fig. 6B). The
Km value for UDP at pH 7 was 216 ± 14 µM (mean ± S.E., n = 3) (Fig.
6C).

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 6.
Catalytic properties of rat full-length
Ca2+-NDPase. A, determination of metal
cation dependence revealed a strong activation by Ca2+
(filled circles) but not by Mg2+ (empty
circles). B, pH dependence of catalytic rate.
C, concentration dependence of catalytic rate. Values are
means ± S.E.; n = 3.
|
|
To further address the solubility of the expressed enzymes, membrane
fractions derived from cells transfected with either the full-length
cDNA, the truncated cDNA, or the empty plasmid were subjected
to Triton X-114 partitioning. Of the specific activity recovered
(30-35%), 1.0 and 99.0% were contained in the aqueous and
hydrophobic phase, respectively, for the full-length enzyme and 5.6 and
94.4%, respectively, for the truncated enzyme (means of two
experiments). This suggests that both forms of the enzyme are
membrane-bound.
To investigate whether catalytic activity was in membrane-occluded form
or facing the surface of the vesicular organelles generated by cell
homogenization in isotonic medium, we compared the catalytic activity
before and after addition of Triton X-100 (0.02%) and after treatment
with proteinase K. At the critical micellar concentration, Triton X-100
caused no reduction in nucleotidase activity. Membrane fractions
derived from mock-transfected cells were compared with those derived
from cells transfected with the full-length Ca2+-NDPase
cDNA. Application of Triton X-100 alone increased 4-fold UDPase
activity of membranes from cells transfected with
Ca2+-NDPase (Fig. 7,
A and B). This catalytic activity was 9.6-fold higher than that obtained under identical conditions with membrane fractions derived from mock-transfected cells (Fig. 7B).
Addition of proteinase K in the absence of Triton X-100 essentially
eliminated catalytic activity (Fig. 7, A and C).
In additional experiments membrane proteins were digested with
proteinase K, followed by inactivation of the enzyme with
phenylmethylsulfonyl fluoride. Membranes were then treated with Triton
X-100 and assayed for Ca2+-NDPase activity. This resulted
in an 42-fold increase in catalytic activity of membranes containing
the recombinant enzyme (Fig. 7, C and D),
suggesting the presence of an occluded and lumenal pool of the enzyme.
Accordingly, catalytic activity was strongly reduced when proteinase K
and Triton X-100 were co-applied (Fig. 7E). Membrane
fractions derived from mock-transfected cells contained an endogenous
lumenal pool of UDPase activity. Catalytic activity was enhanced by a
factor of 2.5 following treatment with Triton X-100 (Fig. 7,
A and B). Furthermore, occluded endogenous UDPase activity could be demonstrated by treatment with proteinase K (Fig. 7,
C and D).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 7.
Lumenal orientation of
Ca2+-NDPase as revealed by proteinase K digestion.
Membrane fractions prepared in isotonic buffer were obtained from cells
transfected with cDNA encoding untagged full-length
Ca2+-NDPase (white bars) or with the empty
plasmid (black bars). Membrane fractions were preincubated
either in the absence or presence of proteinase K (2.5 µg) and Triton
X-100 (0.02%) as indicated. Either Triton X-100 was added together
with proteinase K or membrane fractions were first treated with
proteinase K, followed by inactivation of the enzyme with
phenylmethylsulfonyl fluoride and addition of Triton X-100. Values are
means ± S.E.; n = 3.
|
|
Cellular Localization--
Tagged Ca2+-NDPase was
localized in transfected CHO cells by immunocytochemistry using a
monoclonal antibody against the Myc epitope (Fig.
8). When the antibody was applied to CHO
cells fixed with methanol 2 d after transfection, the protein
could be detected within an intracellular reticular network. To
identify the immunolableled cellular compartment, cells were double
labeled with an antibody directed against calnexin, a chaperone
localized in the ER (26). As shown in Fig. 8, A-D, there is
a high degree of colocalization for the full-length protein, suggesting
that Ca2+-NDPase is targeted to the ER. Double labeling
with WGA, which exhibits strong binding to the medial and trans
cisternae of the Golgi apparatus (27), shows that the
Ca2+-NDPase reveals a cellular distribution different from
the majority of the Golgi compartment (Fig. 8, E and
F). However, when analyzed at high resolution, organellar
compartments with increased Ca2+-NDPase immunoreactivity
were observed in close proximity to individual Golgi stacks (Fig. 8,
G and H). Superimposed images revealed that there
is not direct colocalization. Identical results were obtained with the
truncated form of the protein (data not shown). No immunolabeling could
be obtained when primary antibodies were applied to the surface of
viable cells transfected with either the full-length or the truncated
cDNA (data not shown).

View larger version (116K):
[in this window]
[in a new window]
|
Fig. 8.
Immunocytochemical detection of full-length
Ca2+- NDPase after transfection into CHO cells.
A and B, double labeling for
Ca2+-NDPase (anti-Myc antibody, fluorescein isothiocyanate
immunofluorescence, panel A) and calnexin (indirect CY3
immunofluorescence, panel B). C and D,
high resolution image revealing details of an intracellular reticular
network following double labeling for Ca2+- NDPase
(C) and calnexin (D) as for A and
B. A few examples of colocalization are indicated by
arrowheads. E and F, double labeling
for Ca2+-NDPase (anti-Myc antibody, CY3 immunofluorescence,
panel E) and WGA (AlexaFluor-488TM-labeled,
panel F). The arrow indicates a focus of strong
WGA labeling that is not matched by immunolabeling for
Ca2+-NDPase. G and H, high resolution
confocal image revealing a close apposition of structures double
labeled for Ca2+-NDPase (G) and WGA
(H), as for E and F. The
arrowheads in G and H indicate
identical positions within the two images. Bar indicates 10 µm, A, B, E, F and 3 µm, C, D, G, H.
|
|
 |
DISCUSSION |
Here we describe a novel nucleoside diphosphatase of broad tissue
distribution capable of hydrolyzing UDP, GDP, and IDP. It is activated
by Ca2+ but not by Mg2+, with a maximal
hydrolysis rate between pH 6.5 and 7.5. The amino-terminal sequence
contains three putative start codons, two of which appear to be used,
resulting in the full-length form and traces of a truncated form of the
enzyme. Transfection with a truncated cDNA beginning with the
putative third start codon yielded a truncated protein of functional
properties and cellular localization identical to the full-length
protein. This suggests that the targeting information is located after
the third methionine. The large carboxyl-terminal domain with the
catalytic site faces the organelle lumen.
Ca2+-NDPase displays between 30 and 40% sequence identity
with the C. lectularius and P. papatasi apyrases
(19, 20). It shares strict Ca2+ dependence and a single
potential N-glycosylation site with the two
Cimex-type apyrases. Because of an extended amino terminus, both its calculated and apparent molecular mass is larger (~46 kDa)
than those of the Cimex type apyrases (~36 kDa). A
comparable amino-terminal extension is also observed in the related
vertebrate sequences. In all vertebrate species, the amino terminus
contains the basic RXR ER retention/retrieval motif
situated before the putative transmembrane domain. This motif has been
ascribed to a number of membrane proteins such as ligand-gated ion
channels, G-protein-coupled receptors, or potassium channels. Masking
of the RXR retention/retrieval motif is thought to play an
important role in regulating the forward trafficking of ion channels
and other membrane proteins through the secretory pathway (25). This
motif may be responsible for the retention of the
Ca2+-NDPase within the ER.
Sequence shortening and signal peptide cleavage may be a
specific adaptive feature of the bloodsucking insects. The predicted reading frame in D. melanogaster (44% sequence identity
with Ca2+-NDPase) is even longer than that of the mammalian
sequences. Function and cellular localization of the resulting
Drosophila protein remain to be determined. Multiple
sequence alignment places the insect sequences into a group separate
from the vertebrate sequences. Interestingly, the C. elegans
sequence is grouped into the latter, further supporting the notion of a
separate development of the insect genes. The sequence of
Ca2+-NDPase does not contain consensus sequences identified
in nucleotide binding proteins (28). The distribution over the entire
reading frame of sequence domains highly conserved between C. elegans and mammals suggests that these may cooperate in
nucleotide binding and hydrolysis within the folded protein, similar to
the apyrase conserved regions of the E-NTPDase family (29) and to
conserved sequence domains in the ecto-5'-nucleotidase family (30,
31).
Functionally, Ca2+-NDPase is much more closely related to
intracellularly located members of the E-NTPDase family. Its catalytic properties most resemble those of the two Ca2+- or
Mg2+-activated nucleoside diphosphatases, NTPDase5 and
NTPDase6. NTPDase5 (CD39L4, ER UDPase) isolated from murine liver
revealed a substrate preference of UDP >GDP, IDP >>>ADP, CDP (8),
similar to the heterologously expressed human enzyme (UDP >GDP >CDP
>ADP) (9). Apparently, NTPDase5 resides in the ER and can be
released from cells. The soluble protein has a molecular mass of 45 kDa
and a Km value for UDP of 0.2-0.5 mM
(8), similar to Ca2+-NDPase (216 µM). Rat NTPDase6 reveals a strong substrate
preference for nucleoside diphosphates (GDP >IDP
UDP, CDP
ADP) but is expressed to the Golgi apparatus and partially to the
cell surface and is released from cells (10). The additional
Golgi-localized nucleotidase NTPDase4 (UDPase/hLALPP70v) differs from
the other enzymes by hydrolyzing a variety of nucleoside triphosphates
in addition to UDP and GDP and by its preference for Ca2+
>Mg2+ in activating catalytic activity (5, 7). The exact
subcellular localization of NTPDase7 (LALP1) with its preferred
substrates UTP, GTP, and CTP is still undefined (14). Its catalytic
properties resemble those of the lysosome/autophagic vacuole-located
variant of NTPDase4 (hALAP70) (UTP >TTP >CDP >UDP = CTP)
(7).
A major question is the functional role of the enzymes targeted to ER
and Golgi apparatus. Yeast contains two Golgi-located enzymes related
to NTPDase4 (Ynd1/Apy1p, Refs. 16 and 17) and NTPDase5/6 (yeast GDPase,
Ref. 15) but no sequence related to the Ca2+-NDPase. Double
deletion experiments revealed that the two yeast enzymes are required
for Golgi glycosylation and cell wall integrity (16). Rat NTPDase5
(ER-UDPase) has been suggested to promote reglycosylation reactions
involved in glycoprotein folding and quality control in the ER (8).
According to this model, misfolded proteins are recognized by soluble
UDP-glucose:glycoprotein glycosyltransferase that adds a single glucose
residue back to the trimmed oligosaccharide, resulting in a second
round of folding by a chaperone (26, 32). UDP-glucose required for the
glycosylation reaction is taken up into the ER via a nucleotide
sugar/nucleoside monophosphate antiporter (33, 34). The resulting UDP
is cleaved to UMP by lumenal nucleoside diphosphatase, and the
nucleoside monophosphates formed are then exchanged via the antiporter
system for more nucleotide sugar. An additional possibility would be
that UDP-hydrolyzing enzymes could be involved in the utilization of
UDP derived from UDP-N-acetylglucosamine and UDP-glucuronic
acid that are also imported from the cytosol into the ER lumen (8,
33).
Our results suggest that the ER contains a membrane-bound enzyme with
the capability to hydrolyze UDP, GDP, and IDP, in addition to the
soluble NTPDase5 (ER-UDPase, CD39L4). Although mammalian cells
transport CMP-, GDP-,and UDP-sugars into the Golgi apparatus, only
UDP-sugars are known to be imported into the ER (33). At present the
catalytic potential for the hydrolysis of GDP and IDP within the ER
remains enigmatic. It also needs to be investigated whether the two ER
nucleoside diphosphatases are equally distributed throughout the entire
ER. Following heterologous transfection, Ca2+- NDPase is
targeted to the ER, but the increased immunolabeling at sites close to
WGA-labeled Golgi stacks implies that the enzyme may also enter
membrane compartments intermediate between the ER and Golgi apparatus
(35). Interestingly, the ER protein-folding sensor
UDP-glucose:glycoprotein glycosyltransferase is enriched in pre-Golgi
intermediates, suggesting that this compartment may participate in
protein quality control (36). Because quality control represents an
essential step in the secretory assembly line (26), expression of two
different proteins with overlapping catalytic activities may represent
a safety margin. It is also possible that the preponderance of the two
enzymes varies between cell types and tissues. This notion is supported
by a comparison of our Northern blot analyses with those obtained for
human NTPDase5 (CD39L4) (37).
ATP is actively transported into the ER and Golgi apparatus (38, 39).
Within the ER it serves a variety of energy-requiring reactions,
including protein translocation, dissociation of complexes among
chaperones and correctly folded and assembled proteins, disulfide bond
formation, and lumenal phosphorylation of proteins (33, 40). It is
therefore not surprising that nucleotidases resident both in the ER and
Golgi apparatus lack significant ATPase activity. However, all
nucleotidases, including those hydrolyzing ATP and destined to the cell
surface, need to pass through the ER. This raises the question whether
they are prevented from hydrolyzing nucleotides within the secretory
pathway. It has been shown for the ATP- and ADP-hydrolyzing
ecto-nucleotidase, NTPDase1, that as a result of incomplete
glycosylation the enzyme remains inactive intracellularly (41). Our
investigation adds another nucleotidase to the mammalian cellular
endomembrane system. The multiplicity of nucleoside tri- and/or
diphosphate-hydrolyzing enzymes within the various compartments of the
endomembrane system, including ER (8, 9), Golgi apparatus (5, 10),
lysosomes, autophagic vacuoles (6, 7), and (presumably) additional
organellar structures (14) implies the presence of the substrate
nucleotides in the respective compartments. This provides a challenge
for a more detailed investigation of nucleotide function and metabolism within the endomembrane system.
 |
ACKNOWLEDGEMENT |
We thank Peter Brendel for expert technical support.
 |
FOOTNOTES |
*
This work was supported by grants from the Deutsche
Forschungsgemeinschaft (SFB 269, A4) and the Fonds der Chemischen
Industrie.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the DDBJ/GenBankTM/EBI Data Bank with accession number(s) AJ 312208 and AJ 312207.
To whom correspondence should be addressed. Tel.: 49-69-798-29602;
Fax: 49-69-798-29606; E-mail:
h.zimmermann@zoology.uni-frankfurt.de.
Published, JBC Papers in Press, August 8, 2002, DOI 10.1074/jbc.M201656200
 |
ABBREVIATIONS |
The abbreviations used are:
E-NTPDase, ecto-nucleoside triphosphate diphosphohydrolase;
CHO, Chinese hamster
ovary;
ER, endoplasmic reticulum;
CY3, indocarbocyanin-3;
EST, expressed sequence tag;
NDPase, nucleoside diphosphatase;
TM, transmembrane domain;
WGA, wheat germ agglutinin.
 |
REFERENCES |
| 1.
|
Zimmermann, H.
(2001)
in
Handbook of Experimental Pharmacology. Purinergic and Pyrimidergic Signalling I
(Abbracchio, M. P.
, and Williams, M., eds)
, pp. 209-250, Springer Verlag, Heidelberg
|
| 2.
|
Zimmermann, H.
(2001)
Drug Dev. Res.
52,
44-56[CrossRef]
|
| 3.
|
Enjyoji, K.,
Sévigny, J.,
Lin, Y.,
Frenette, P.,
Christie, P. D.,
Schulte am Esch, J.,
Imai, M.,
Edelberger, J. M.,
Rayburn, H.,
Lech, M.,
Beeler, D. M.,
Csizmadia, E.,
Wagner, D. D.,
Robson, S. C.,
and Rosenberg, R. D.
(1999)
Nat. Med.
5,
1010-1017[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Dunwiddie, T. V.,
Diao, L. H.,
and Proctor, W. R.
(1997)
J. Neurosci.
17,
7673-7682[Abstract/Free Full Text]
|
| 5.
|
Wang, T. F.,
and Guidotti, G.
(1998)
J. Biol. Chem.
273,
11392-11399[Abstract/Free Full Text]
|
| 6.
|
Biederbick, A.,
Rose, S.,
and Elsässer, H. P.
(1999)
J. Cell Sci.
112,
2473-2484[Abstract]
|
| 7.
|
Biederbick, A.,
Kosan, C.,
Kunz, J.,
and Elsässer, H. P.
(2000)
J. Biol. Chem.
275,
19018-19024[Abstract/Free Full Text]
|
| 8.
|
Trombetta, E. S.,
and Helenius, A.
(1999)
EMBO J.
18,
3282-3292[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Mulero, J. J.,
Yeung, G.,
Nelken, S. T.,
and Ford, J. E.
(1999)
J. Biol. Chem.
29,
20064-20067
|
| 10.
|
Braun, N.,
Fengler, S.,
Ebeling, C.,
Servos, J.,
and Zimmermann, H.
(2000)
Biochem. J.
351,
639-647[Medline]
[Order article via Infotrieve]
|
| 11.
|
Hicks-Berger, C. A.,
Chadwick, B. P.,
Frischauf, A. M.,
and Kirley, T. L.
(2000)
J. Biol. Chem.
275,
34041-34045[Abstract/Free Full Text]
|
| 12.
|
Mulero, J. J.,
Yeung, G.,
Nelken, S. T.,
Bright, J. M.,
McGowan, D. W.,
and Ford, J. E.
(2000)
Biochemistry
39,
12924-12928[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Yeung, G.,
Mulero, J. J.,
McGowan, D. W.,
Bajwa, S. S.,
and Ford, J. E.
(2000)
Biochemistry
39,
12916-12923[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Shi, J. D.,
Kukar, T.,
Wang, C. Y., Li, Q. Z.,
Cruz, P. E.,
Davoodi-Semiromi, A.,
Yang, P., Gu, Y. R.,
Lian, W., Wu, D. H.,
and She, J. X.
(2001)
J. Biol. Chem.
276,
17474-17478[Abstract/Free Full Text]
|
| 15.
|
Abeijon, C.,
Yanagisawa, K.,
Mandon, E. C.,
Häusler, A.,
Moremen, K.,
Hirschberg, C. B.,
and Robbins, P. W.
(1993)
J. Cell Biol.
122,
307-323[Abstract/Free Full Text]
|
| 16.
|
Gao, X. D.,
Kaigorodov, V.,
and Jigami, Y.
(1999)
J. Biol. Chem.
274,
21450-21456[Abstract/Free Full Text]
|
| 17.
|
Zhong, X. T.,
and Guidotti, G.
(1999)
J. Biol. Chem.
274,
32704-32711[Abstract/Free Full Text]
|
| 18.
|
Lopez-Avalos, M. D.,
Uccelletti, D.,
Abeijon, C.,
and Hirschberg, C. B.
(2001)
Glycobiology
11,
413-422[Abstract/Free Full Text]
|
| 19.
|
Valenzuela, J. G.,
Charlab, R.,
Galperin, M. Y.,
and Ribeiro, J. M. C.
(1998)
J. Biol. Chem.
273,
30583-30590[Abstract/Free Full Text]
|
| 20.
|
Valenzuela, J. G.,
Belkaid, Y.,
Rowton, E.,
and Ribeiro, J. M. C.
(2001)
J. Exp. Biol.
204,
229-237[Abstract]
|
| 21.
|
Kyte, J.,
and Doolittle, R. F.
(1982)
J. Mol. Biol.
157,
105-132[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Kegel, B.,
Braun, N.,
Heine, P.,
Maliszewski, C. R.,
and Zimmermann, H.
(1997)
Neuropharmacology
36,
1189-1200[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Lanzetta, P. A.,
Alvarez, L. J.,
Reinach, P. S.,
and Candia, O. A.
(1979)
Anal. Biochem.
100,
95-97[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Heilbronn, A.,
Krapohl, A.,
and Zimmermann, H.
(1995)
Cell Tissue Res.
280,
123-131[CrossRef]
|
| 25.
|
Scott, D. B.,
Blanpied, T. A.,
Swanson, G. T.,
Zhang, C.,
and Ehlers, M. D.
(2001)
J. Neurosci.
21,
3063-3072[Abstract/Free Full Text]
|
| 26.
|
Helenius, A.
(2001)
Philos. Trans. R. Soc. Lond.-Biol. Sci.
356,
147-150[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Parkkinen, J. J.,
Lammi, M. J.,
Agren, U.,
Tammi, M.,
Keinanen, T. A.,
Hyvonen, T.,
and Eloranta, T. O.
(1997)
J. Cell. Biochem.
66,
165-174[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Saraste, M.,
Sibbald, P. R.,
and Wittinghofer, A.
(1990)
Trends Biochem. Sci.
15,
430-434[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Yang, F.,
Hicks-Berger, C. A.,
Smith, T. M.,
and Kirley, T. L.
(2001)
Biochemistry
40,
3943-3950[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Zimmermann, H.
(1992)
Biochem. J.
285,
345-365[Medline]
[Order article via Infotrieve]
|
| 31.
|
Knöfel, T.,
and Sträter, N.
(1999)
Nat. Struct. Biol.
6,
448-453[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Ellgaard, L.,
Molinari, M.,
and Helenius, A.
(1999)
Science
286,
1882-1888[Abstract/Free Full Text]
|
| 33.
|
Hirschberg, C. B.,
Robbins, P. W.,
and Abeijon, C.
(1998)
Annu. Rev. Biochem.
67,
49-69[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Castro, O.,
Chen, L. Y.,
Parodi, A. J.,
and Abeijón, C.
(1999)
Mol. Biol. Cell
10,
1019-1030[Abstract/Free Full Text]
|
| 35.
|
Gomord, V.,
Wee, E.,
and Faye, L.
(1999)
Biochimie (Paris)
81,
607-618[CrossRef]
|
| 36.
|
Zuber, C.,
Fan, J.-Y.,
Guhl, B.,
Parodi, A.,
Fessler, J. H.,
Parker, C.,
and Roth, J.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
10710-10715[Abstract/Free Full Text]
|
| 37.
|
Chadwick, B. P.,
and Frischauf, A. M.
(1998)
Genomics
50,
357-367[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Guillen, E.,
and Hirschberg, C. B.
(1995)
Biochemistry
34,
5472-5476[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Puglielli, L.,
Mandon, E. C.,
and Hirschberg, C. B.
(1999)
J. Biol. Chem.
274,
12665-12669[Abstract/Free Full Text]
|
| 40.
|
Bukau, B.,
and Horwich, A. L.
(1998)
Cell
92,
351-366[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Zhong, X. T.,
Malhotra, R.,
Woodruff, R.,
and Guidotti, G.
(2001)
J. Biol. Chem.
276,
41518-41525[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Uccelletti, A. Pascoli, F. Farina, A. Alberti, P. Mancini, C. B. Hirschberg, and C. Palleschi
APY-1, a Novel Caenorhabditis elegans Apyrase Involved in Unfolded Protein Response Signalling and Stress Responses
Mol. Biol. Cell,
April 1, 2008;
19(4):
1337 - 1345.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Yang, K. Horii, A. B. Herr, and T. L. Kirley
Calcium-dependent Dimerization of Human Soluble Calcium Activated Nucleotidase: CHARACTERIZATION OF THE DIMER INTERFACE
J. Biol. Chem.,
September 22, 2006;
281(38):
28307 - 28317.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D'Alessio, J. J. Caramelo, and A. J. Parodi
Absence of Nucleoside Diphosphatase Activities in the Yeast Secretory Pathway Does Not Abolish Nucleotide Sugar-dependent Protein Glycosylation
J. Biol. Chem.,
December 9, 2005;
280(49):
40417 - 40427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Uccelletti, C. O'Callaghan, P. Ber |